Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Low daily doses of rimonabant reduce responses to cannabis

Nov. 30, 2007

E.U. approves Merck Serono's Cyanokit for cyanide poisoning

Nov. 29, 2007

Tiagabine ineffective in cocaine dependence study

Nov. 22, 2007

DOR BioPharma enters cooperative agreement for RiVax with Walter Reed Army Institute

Nov. 21, 2007

Acrux initiates production of Nicotine MDTS following successful phase I clinical trial

Nov. 16, 2007

Aeolus's AEOL-10150 demonstrates protection against mustard gas

Nov. 12, 2007

Celtic Pharma completes enrollment in phase IIb TA-NIC study

Nov. 6, 2007

Treatment option for opioid dependency imparted in recent Reckitt Benckiser patent

Nov. 5, 2007

Aripiprazole ineffective in treating methamphetamine dependence

Oct. 26, 2007

Novel selective D3 antagonist from GSK

Oct. 19, 2007

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...